BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8656244)

  • 21. Reoperative retroperitoneal surgery for nonseminomatous germ cell tumor: clinical presentation, patterns of recurrence, and outcome.
    McKiernan JM; Motzer RJ; Bajorin DF; Bacik J; Bosl GJ; Sheinfeld J
    Urology; 2003 Oct; 62(4):732-6. PubMed ID: 14550453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed orchiectomy after chemotherapy in patients with advanced testicular cancer.
    Ondrus D; Hornák M; Breza J; Mat'oska J; Schnorrer M; Belan V; Kausitz J
    Int Urol Nephrol; 2001; 32(4):665-7. PubMed ID: 11989561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-stage approach for retroperitoneal and mediastinal metastatic testicular tumor resection.
    Fadel E; Court B; Chapelier AR; Droz JP; Dartevelle P
    Ann Thorac Surg; 2000 Jun; 69(6):1717-21. PubMed ID: 10892913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resection of pulmonary metastases following chemotherapy for high stage testicular tumors.
    Eskicorapci SY; Ekici S; Atsu MN; Dogan R; Ozen H
    Int J Urol; 2004 Aug; 11(8):634-9. PubMed ID: 15285754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
    J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
    Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
    Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed orchiectomy after chemotherapy for metastatic nonseminomatous germ cell tumors.
    Leibovitch I; Little JS; Foster RS; Rowland RG; Bihrle R; Donohue JP
    J Urol; 1996 Mar; 155(3):952-4. PubMed ID: 8583615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integration of surgery and systemic therapy: results and principles of integration.
    Donohue JP; Leviovitch I; Foster RS; Baniel J; Tognoni P
    Semin Urol Oncol; 1998 May; 16(2):65-71. PubMed ID: 9649229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do all germ cell tumor patients with residual masses in multiple sites require postchemotherapy resections?
    Einhorn LH
    J Clin Oncol; 1997 Jan; 15(1):409-10. PubMed ID: 8996171
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post-chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses.
    Nakamura T; Oishi M; Ueda T; Fujihara A; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Urol; 2015 Jul; 22(7):663-8. PubMed ID: 25847721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients.
    Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R
    Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-chemotherapy residual mass in non-seminomatous testicular cancer. The role of retroperitoneal lymph node dissection.
    El Sayed S; Grando JP; Almeida SH; Mortati Neto N; Moreira HA
    Int Braz J Urol; 2004; 30(5):384-8. PubMed ID: 15610570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
    Fizazi K; Tjulandin S; Salvioni R; Germà-Lluch JR; Bouzy J; Ragan D; Bokemeyer C; Gerl A; Fléchon A; de Bono JS; Stenning S; Horwich A; Pont J; Albers P; De Giorgi U; Bower M; Bulanov A; Pizzocaro G; Aparicio J; Nichols CR; Théodore C; Hartmann JT; Schmoll HJ; Kaye SB; Culine S; Droz JP; Mahé C
    J Clin Oncol; 2001 May; 19(10):2647-57. PubMed ID: 11352956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous Vs Sequential Retroperitoneal, Thoracic and Cervical Resection of Post Chemotherapy Residual Masses in Patients With Metastatic Nonseminomatous Germ Cell Tumors of the Testis.
    Nason GJ; Donahoe L; de Perrot M; Aditya I; Jewett MAS; Bedard PL; Hansen AR; Chung P; Warde P; Anson-Cartwright L; Sweet J; O'Malley M; Atenafu EG; Hamilton RJ
    Urology; 2020 Apr; 138():69-76. PubMed ID: 32004556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgery for testicular cancer: indication, results and technical aspects.
    Khouni H; Ghozzi S; Ramzi K; Smaali CH; Majed H; Ben Rais N
    Tunis Med; 2005 Dec; 83 Suppl 12():78-83. PubMed ID: 16430075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contemporary management of postchemotherapy testis cancer.
    Daneshmand S; Albers P; Fosså SD; Heidenreich A; Kollmannsberger C; Krege S; Nichols C; Oldenburg J; Wood L
    Eur Urol; 2012 Nov; 62(5):867-76. PubMed ID: 22938868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical study of retroperitoneal lymph node dissection for patients with advanced germ cell tumors].
    Okamura K; Yuba H; Nishimura T; Mizutani K; Takashi M; Gotoh M; Ono Y; Ohshima S
    Hinyokika Kiyo; 1999 Feb; 45(2):95-101. PubMed ID: 10212781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
    Beck SD; Foster RS; Bihrle R; Ulbright T; Koch MO; Wahle GR; Einhorn LH; Donohue JP
    J Urol; 2002 Oct; 168(4 Pt 1):1402-4. PubMed ID: 12352402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The significance of resections for residual masses after chemotherapy in metastatic testicular tumors.
    Suzuki K; Orikasa S; Hoshi S; Yoshikawa K; Saito S; Ohyama C; Sato M; Kawamura S; Numahata K; Ito A; Tokuyama S
    Int J Urol; 1999 Jun; 6(6):305-13. PubMed ID: 10404307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.